Evidence map›Paper›PMID 36261218›Full record

ArticleOpen heart2022

Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement.

Mark Lachmann, Elena Rippen, Tibor Schuster, Erion Xhepa, Moritz von Scheidt, Teresa Trenkwalder, Costanza Pellegrini, Tobias Rheude, Amelie Hesse, Anja Stundl and 7 more

Abstract read
In one paragraph

Article in Open heart, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Artificial intelligence in the clinical management and prognostication of mitral regurgitation: a systematic review.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2026
    Review
  2. Article
  3. Harnessing Artificial Intelligence for Innovation in Interventional Cardiovascular Care.Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Mark LachmannFirst Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.ORCID 0000-0002-1798-550X
Elena RippenFirst Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Tibor SchusterDepartment of Family Medicine, McGill University, Montreal, Quebec, Canada.
Erion XhepaDZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.ORCID 0000-0002-0728-2819
Moritz von ScheidtDZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Teresa TrenkwalderDZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Costanza PellegriniDepartment of Cardiology, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany.
Tobias RheudeDepartment of Cardiology, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany.
Amelie HesseFirst Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Anja StundlFirst Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Gerhard HarmsenDepartment of Physics, University of Johannesburg, Auckland Park, South Africa.
Shinsuke YuasaDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Heribert SchunkertDZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Adnan KastratiDZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Karl-Ludwig LaugwitzFirst Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Michael JonerDZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Christian KupattFirst Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany christian.kupatt@tum.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveA novel artificial intelligence-based phenotyping approach to stratify patients with severe aortic stenosis (AS) prior to transcatheter aortic valve replacement (TAVR) has been proposed, based on echocardiographic and haemodynamic data. This study aimed to analyse the recovery of extra-aortic valve cardiac damage in accordance with this novel stratification system following TAVR.

methodsThe proposed phenotyping approach was previously established employing data from 366 patients with severe AS from a bicentric registry. For this consecutive study, echocardiographic follow-up data, obtained on day 147±75.1 after TAVR, were available from 247 patients (67.5%).

resultsCorrection of severe AS by TAVR significantly reduced the proportion of patients suffering from concurrent severe mitral regurgitation (from 9.29% to 3.64%, p value: 0.0015). Moreover, pulmonary artery pressures were ameliorated (estimated systolic pulmonary artery pressure: from 47.2±15.8 to 43.3±15.1 mm Hg, p value: 0.0079). However, right heart dysfunction as well as the proportion of patients with severe tricuspid regurgitation remained unchanged. Clusters with persistent right heart dysfunction ultimately displayed 2-year survival rates of 69.2% (95% CI 56.6% to 84.7%) and 74.6% (95% CI 65.9% to 84.4%), which were significantly lower compared with clusters with little or no persistent cardiopulmonary impairment (88.3% (95% CI 83.3% to 93.5%) and 85.5% (95% CI 77.1% to 94.8%)).

conclusionsThis phenotyping approach preprocedurally identifies patients with severe AS, who will not recover from extra-aortic valve cardiac damage following TAVR and whose survival is therefore significantly reduced. Importantly, not the degree of pulmonary hypertension at initial presentation, but the irreversibility of right heart dysfunction determines prognosis.

Indexed as

Aortic Valve StenosisTranscatheter Aortic Valve ReplacementAortic ValveArtificial IntelligenceHumansTreatment Outcomeaortic valve stenosisechocardiographytranscatheter aortic valve replacement

Identifiers

PMID36261218
PMCPMC9582320

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.